Jacobs Levy Equity Management Portfolio holdings
AUM
$25.5B
1-Year Return
20.81%
This Quarter Return
+26.16%
1 Year Return
+20.81%
3 Year Return
+97.14%
5 Year Return
+210.43%
10 Year Return
+444.59%
AUM
$11.4B
AUM Growth
+$1.76B
(+18%)
Cap. Flow
-$363M
Cap. Flow
% of AUM
-3.18%
Top 10 Holdings %
Top 10 Hldgs %
18.38%
Holding
1,151
New
138
Increased
341
Reduced
503
Closed
147
Top Buys
| 1 |
APA Corp
APA
|
$33.6M |
| 2 |
Amazon
AMZN
|
$32.7M |
| 3 |
Intel
INTC
|
$29.2M |
| 4 |
Gilead Sciences
GILD
|
$26.7M |
| 5 |
Devon Energy
DVN
|
$26.4M |
Top Sells
| 1 |
Altice USA
ATUS
|
$41M |
| 2 |
Align Technology
ALGN
|
$38.9M |
| 3 |
Qualcomm
QCOM
|
$36.7M |
| 4 |
CBRE Group
CBRE
|
$31.9M |
| 5 |
MetLife
MET
|
$30.3M |
Sector Composition
| 1 | Technology | 26.78% |
| 2 | Healthcare | 14.08% |
| 3 | Consumer Discretionary | 13.88% |
| 4 | Financials | 13.05% |
| 5 | Industrials | 8.65% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
CSR
401
Centerspace
CSR
$1.01B
| $4.96M | 0.04% |
70,181
-2,421
| -3% | -$171K |
|
402
Avient
AVNT
$3.45B
| $4.94M | 0.04% |
122,568
-3,504
| -3% | -$141K |
|
|
ODT
403
DELISTED
Odonate Therapeutics, Inc. Common Stock
ODT
| $4.9M | 0.04% |
255,202
+178,169
| +231% | +$3.42M |
|
404
Editas Medicine
EDIT
$248M
| $4.86M | 0.04% |
69,345
-20,675
| -23% | -$1.45M |
|
|
DBD
405
DELISTED
Diebold Nixdorf Incorporated
DBD
| $4.83M | 0.04% |
452,835
-22,469
| -5% | -$240K |
|
406
AT&T
T
$212B
| $4.8M | 0.04% |
221,103
+7,060
| +3% | +$153K |
|
407
Axcelis
ACLS
$2.53B
| $4.74M | 0.04% |
162,657
-4,917
| -3% | -$143K |
|
408
Jack in the Box
JACK
$386M
| $4.72M | 0.04% |
50,849
-13,611
| -21% | -$1.26M |
|
409
Accuray
ARAY
$170M
| $4.66M | 0.04% |
1,116,320
-35,549
| -3% | -$148K |
|
410
Apellis Pharmaceuticals
APLS
$3.55B
| $4.6M | 0.04% |
80,381
-39,862
| -33% | -$2.28M |
|
411
FibroGen
FGEN
$48.9M
| $4.54M | 0.04% |
4,892
-2,833
| -37% | -$2.63M |
|
412
Andersons Inc
ANDE
$1.42B
| $4.52M | 0.04% |
184,451
+117,823
| +177% | +$2.89M |
|
413
Scholastic
SCHL
$654M
| $4.51M | 0.04% |
180,200
-1,050
| -0.6% | -$26.3K |
|
414
Corpay
CPAY
$22.4B
| $4.48M | 0.04% |
16,435
-1,369
| -8% | -$374K |
|
415
H&R Block
HRB
$6.85B
| $4.46M | 0.04% |
280,878
-1,841,619
| -87% | -$29.2M |
|
416
Allegiant Air
ALGT
$1.18B
| $4.42M | 0.04% |
23,380
+53
| +0.2% | +$10K |
|
417
Inspire Medical Systems
INSP
$2.56B
| $4.4M | 0.04% |
23,392
-2,000
| -8% | -$376K |
|
418
Universal Insurance Holdings
UVE
$697M
| $4.38M | 0.04% |
289,632
-1,387
| -0.5% | -$21K |
|
419
Civitas Resources
CIVI
$3.19B
| $4.37M | 0.04% |
226,019
-15,010
| -6% | -$290K |
|
420
Surmodics
SRDX
$463M
| $4.36M | 0.04% |
100,197
-26,914
| -21% | -$1.17M |
|
421
Acco Brands
ACCO
$364M
| $4.36M | 0.04% |
+515,894
| New | +$4.36M |
|
422
OneSpan
OSPN
$583M
| $4.35M | 0.04% |
+210,530
| New | +$4.35M |
|
423
Coherus Oncology, Inc. Common Stock
CHRS
$150M
| $4.35M | 0.04% |
250,134
+100,489
| +67% | +$1.75M |
|
424
Hilltop Holdings
HTH
$2.22B
| $4.31M | 0.04% |
156,626
-6,074
| -4% | -$167K |
|
425
Tyson Foods
TSN
$20B
| $4.25M | 0.04% |
+65,912
| New | +$4.25M |
|